Close Menu

UK government

Nobel laureates bemoan the potential effects of a no-deal Brexit on science in the UK, the Guardian reports.

The project is funded with £50 million from the UK government, £50 million from the Wellcome Trust, and £100 million from four pharmaceutical firms.

UK Prime Minister Boris Johnson has announced a plan for "fast-track visas" to attract scientific talent to the UK post-Brexit, the Financial Times reports.

New UK Prime Minister Boris Johnson has selected his brother Jo Johnson, who is largely liked by researchers, to join the cabinet, Nature News reports.

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

The UK Competition and Markets Authority has announced concerns that the $1.2 billion merger will reduce competition for Illumina and could scrutinize it further.

On the Horizon

Paul Nurse, the director of the Francis Crick Institute, says British science will suffer if the UK isn't part of Horizon Europe funding scheme, according to the Guardian.

But Also, Education

The Campaign for Science and Engineering's Sarah Main writes at the Guardian that increased R&D spending should also come with investment in education.

The Competition and Markets Authority is in charge of promoting competition and reducing anti-competitive activities in the UK.

The project dovetails with a separate effort to sequence the whole exomes of the samples, the first 50,000 of which became available to researchers this month.

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.